Frontiers in Systems Biology,
Journal Year:
2025,
Volume and Issue:
4
Published: Jan. 7, 2025
Post-Acute
Sequelae
of
SARS-CoV-2
infection
(PASC
or
“Long
COVID”),
includes
numerous
chronic
conditions
associated
with
widespread
morbidity
and
rising
healthcare
costs.
PASC
has
highly
variable
clinical
presentations,
likely
multiple
molecular
subtypes,
but
it
remains
poorly
understood
from
a
mechanistic
standpoint.
This
hampers
the
development
rationally
targeted
therapeutic
strategies.
The
NIH-sponsored
“Researching
COVID
to
Enhance
Recovery”
(RECOVER)
initiative
several
retrospective/prospective
observational
cohort
studies
enrolling
adult,
pregnant
adult
pediatric
patients
respectively.
RECOVER
formed
an
“OMICS”
multidisciplinary
task
force,
including
clinicians,
pathologists,
laboratory
scientists
data
scientists,
charged
developing
recommendations
apply
cutting-edge
system
biology
technologies
achieve
goals
RECOVER.
force
met
biweekly
over
14
months,
evaluate
published
evidence,
examine
possible
contribution
each
“omics”
technique
study
develop
design
recommendations.
OMICS
recommended
integrated,
longitudinal,
simultaneous
systems
participant
biospecimens
on
entire
cohorts
through
centralized
laboratories,
as
opposed
smaller
using
one
few
analytical
techniques.
resulting
multi-dimensional
dataset
should
be
correlated
deep
phenotyping
performed
RECOVER,
well
information
demographics,
comorbidities,
social
determinants
health,
exposome
lifestyle
factors
that
may
contribute
presentations
PASC.
approach
will
minimize
lab-to-lab
technical
variability,
maximize
sample
size
for
class
discovery,
enable
incorporation
many
relevant
variables
into
statistical
models.
Many
our
have
already
been
considered
by
NIH
peer-review
process,
in
creation
panel
is
currently
designing
we
proposed.
strategy,
coupled
modern
science
approaches,
dramatically
improve
prospects
accurate
disease
subtype
identification,
biomarker
discovery
target
identification
precision
treatment.
made
available
scientific
community
secondary
analyses.
Analogous
approaches
built
designs
large
whenever
possible.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: March 20, 2023
Metabolic
abnormalities
lead
to
the
dysfunction
of
metabolic
pathways
and
metabolite
accumulation
or
deficiency
which
is
well-recognized
hallmarks
diseases.
Metabolite
signatures
that
have
close
proximity
subject's
phenotypic
informative
dimension,
are
useful
for
predicting
diagnosis
prognosis
diseases
as
well
monitoring
treatments.
The
lack
early
biomarkers
could
poor
serious
outcomes.
Therefore,
noninvasive
methods
with
high
specificity
selectivity
desperately
needed.
Small
molecule
metabolites-based
metabolomics
has
become
a
specialized
tool
biomarker
pathway
analysis,
revealing
possible
mechanisms
human
various
deciphering
therapeutic
potentials.
It
help
identify
functional
related
variation
delineate
biochemical
changes
indicators
pathological
damage
prior
disease
development.
Recently,
scientists
established
large
number
profiles
reveal
underlying
networks
target
exploration
in
biomedicine.
This
review
summarized
analysis
on
potential
value
small-molecule
candidate
metabolites
clinical
events,
may
better
diagnosis,
prognosis,
drug
screening
treatment.
We
also
discuss
challenges
need
be
addressed
fuel
next
wave
breakthroughs.
Cell,
Journal Year:
2023,
Volume and Issue:
186(22), P. 4851 - 4867.e20
Published: Oct. 1, 2023
Post-acute
sequelae
of
COVID-19
(PASC,
"Long
COVID")
pose
a
significant
global
health
challenge.
The
pathophysiology
is
unknown,
and
no
effective
treatments
have
been
found
to
date.
Several
hypotheses
formulated
explain
the
etiology
PASC,
including
viral
persistence,
chronic
inflammation,
hypercoagulability,
autonomic
dysfunction.
Here,
we
propose
mechanism
that
links
all
four
in
single
pathway
provides
actionable
insights
for
therapeutic
interventions.
We
find
PASC
are
associated
with
serotonin
reduction.
Viral
infection
type
I
interferon-driven
inflammation
reduce
through
three
mechanisms:
diminished
intestinal
absorption
precursor
tryptophan;
platelet
hyperactivation
thrombocytopenia,
which
impacts
storage;
enhanced
MAO-mediated
turnover.
Peripheral
reduction,
turn,
impedes
activity
vagus
nerve
thereby
impairs
hippocampal
responses
memory.
These
findings
provide
possible
explanation
neurocognitive
symptoms
persistence
Long
COVID,
may
extend
other
post-viral
syndromes.
Metabolites,
Journal Year:
2022,
Volume and Issue:
12(11), P. 1026 - 1026
Published: Oct. 26, 2022
Exercise
intolerance
is
a
major
manifestation
of
post-acute
sequelae
severe
acute
respiratory
syndrome
coronavirus
infection
(PASC,
or
"long-COVID").
in
PASC
associated
with
higher
arterial
blood
lactate
accumulation
and
lower
fatty
acid
oxidation
rates
during
graded
exercise
tests
to
volitional
exertion,
suggesting
altered
metabolism
mitochondrial
dysfunction.
It
remains
unclear
whether
the
profound
disturbances
that
have
been
identified
plasma
from
patients
suffering
disease
2019
(COVID-19)
are
also
present
PASC.
To
bridge
this
gap,
individuals
history
previous
COVID-19
did
not
require
hospitalization
were
enrolled
at
National
Jewish
Health
(Denver,
CO,
USA)
grouped
into
those
developed
(n
=
29)
fully
recovered
16).
Plasma
samples
two
groups
analyzed
via
mass
spectrometry-based
untargeted
metabolomics
compared
against
metabolic
profiles
healthy
control
30).
Observational
demographic
clinical
data
retrospectively
abstracted
medical
record.
Compared
controls
who
COVID-19,
exhibited
significantly
free-
carnitine-conjugated
mono-,
poly-,
highly
unsaturated
acids,
accompanied
by
markedly
levels
di-
tricarboxylates
(pyruvate,
lactate,
citrate,
succinate,
malate),
polyamines
(spermine)
taurine.
an
intermediary
phenotype,
milder
spermine
Of
note,
depletion
tryptophan-a
hallmark
severity
COVID-19-is
normalized
patients,
despite
normalization
kynurenine
levels-a
tryptophan
metabolite
predicts
mortality
hospitalized
patients.
In
conclusion,
metabolites
indicative
dysfunctional
mitochondria-dependent
lipid
catabolism.
These
obtained
rest
consistent
previously
reported
dysfunction
exercise,
may
pave
way
for
therapeutic
intervention
focused
on
restoring
fat-burning
capacity.
Frontiers in Molecular Biosciences,
Journal Year:
2023,
Volume and Issue:
10
Published: Feb. 15, 2023
COVID-19
currently
represents
one
of
the
major
health
challenges
worldwide.
Albeit
its
infectious
character,
with
onset
affectation
mainly
at
respiratory
track,
it
is
clear
that
pathophysiology
has
a
systemic
ultimately
affecting
many
organs.
This
feature
enables
possibility
investigating
SARS-CoV-2
infection
using
multi-omic
techniques,
including
metabolomic
studies
by
chromatography
coupled
to
mass
spectrometry
or
nuclear
magnetic
resonance
(NMR)
spectroscopy.
Here
we
review
extensive
literature
on
metabolomics
in
COVID-19,
unraveled
aspects
disease
including:
characteristic
metabotipic
signature
associated
discrimination
patients
according
severity,
effect
drugs
and
vaccination
treatments
characterization
natural
history
metabolic
evolution
disease,
from
full
recovery
long-term
long
sequelae
COVID.
Gut,
Journal Year:
2023,
Volume and Issue:
72(8), P. 1581 - 1591
Published: Feb. 14, 2023
Background
and
aims
Current
prognostic
scores
of
patients
with
acutely
decompensated
cirrhosis
(AD),
particularly
those
acute-on-chronic
liver
failure
(ACLF),
underestimate
the
risk
mortality.
This
is
probably
because
systemic
inflammation
(SI),
major
driver
AD/ACLF,
not
reflected
in
scores.
SI
induces
metabolic
changes,
which
impair
delivery
necessary
energy
for
immune
reaction.
investigation
aimed
to
identify
metabolites
associated
short-term
(28-day)
death
design
metabolomic
models.
Methods
Two
prospective
multicentre
large
cohorts
from
Europe
investigating
ACLF
development
ACLF,
CANONIC
(discovery,
n=831)
PREDICT
(validation,
n=851),
were
explored
by
untargeted
serum
metabolomics
validate
could
allow
improved
modelling.
Results
Three
strongly
selected
build
4-Hydroxy-3-methoxyphenylglycol
sulfate
a
norepinephrine
derivative,
may
be
derived
brainstem
response
SI.
Additionally,
galacturonic
acid
hexanoylcarnitine
are
mitochondrial
dysfunction.
Model
1
included
only
these
three
age.
2
was
built
around
4-hydroxy-3-methoxyphenylglycol
sulfate,
hexanoylcarnitine,
bilirubin,
international
normalised
ratio
(INR)
In
discovery
cohort,
both
models
more
accurate
predicting
within
7,
14
28
days
after
admission
compared
MELDNa
score
(C-index:
0.9267,
0.9002
0.8424,
0.9369,
0.9206
0.8529,
model
2,
respectively).
Similar
results
found
validation
cohort
0.940,
0.834
0.791,
0.947,
0.857
0.810,
Also,
outperformed
prediction
Conclusions
Models
including
(CLIF-C
MET)
reflecting
SI,
dysfunction
sympathetic
system
activation
better
predictors
mortality
than
based
on
organ
(eg,
MELDNa),
especially
ACLF.
Metabolites,
Journal Year:
2025,
Volume and Issue:
15(1), P. 44 - 44
Published: Jan. 11, 2025
Background/Objectives:
Respiratory
viruses,
including
Influenza,
RSV,
and
COVID-19,
cause
various
respiratory
infections.
Distinguishing
these
viruses
relies
on
diagnostic
methods
such
as
PCR
testing.
Challenges
stem
from
overlapping
symptoms
the
emergence
of
new
strains.
Advanced
diagnostics
are
crucial
for
accurate
detection
effective
management.
This
study
leveraged
nasopharyngeal
metabolome
data
to
predict
virus
scenarios
control
vs.
Influenza
A,
all
COVID-19
A/RSV.
Method:
We
proposed
a
stacking-based
ensemble
technique,
integrating
top
three
best-performing
ML
models
initial
results
enhance
prediction
accuracy
by
leveraging
strengths
multiple
base
learners.
Key
techniques
feature
ranking,
standard
scaling,
SMOTE
were
used
address
class
imbalances,
thus
enhancing
model
robustness.
SHAP
analysis
identified
metabolites
influencing
positive
predictions,
thereby
providing
valuable
insights
into
markers.
Results:
Our
approach
not
only
outperformed
existing
but
also
revealed
dominant
features
predicting
Lysophosphatidylcholine
acyl
C18:2,
Kynurenine,
Phenylalanine,
Valine,
Tyrosine,
Aspartic
Acid
(Asp).
Conclusions:
demonstrates
effectiveness
scenarios.
The
enhances
accuracy,
provides
key
markers,
offers
robust
framework
managing
Biomedicines,
Journal Year:
2025,
Volume and Issue:
13(3), P. 535 - 535
Published: Feb. 20, 2025
Background/Objectives:
People
affected
by
COVID-19
are
exposed
to
abnormal
clotting
and
endothelial
dysfunction,
which
may
trigger
thromboembolic
events.
This
study
aimed
at
retrospectively
investigating
whether
oral
anticoagulant
therapy
(OAT),
encompassing
either
direct
anticoagulants
(DOACs),
mainly
apixaban,
or
the
vitamin
K
antagonist
(VKA)
warfarin,
could
have
impacted
medium-term
mortality
in
a
cohort
of
SARS-CoV-2
patients.
Methods:
Among
1238
patients,
hospitalized
from
17
March
2020
15
June
2021,
247
survivors
deceased
within
90
days
hospitalization
were
matched
1:1
based
on
age,
sex,
intensive
care
unit
(ICU)
admission
three
days.
Conditional
logistic
regression
was
used
estimate
associations
means
odds
ratio
(OR)
with
95%
confidence
interval
(CI).
Results:
A
univariate
analysis
suggested
that
OAT,
no
differently
subcutaneous
low-molecular-weight
heparins
(LMWHs)
during
hospitalization,
has
significant
impact
(p
value
>
0.05)
mortality.
multivariate
analysis,
limited
baseline
variables
(i.e.,
comorbidities
pharmacotherapies
hospital
admission)
showing
association
<
revealed
that,
compared
patients
living
had
cancer
histories
(OR
1.75,
CI
1.06–2.90,
p
=
0.029)
suffered
asthma
2.25,
1.13–4.47,
0.021).
In
contrast,
heart
failure
(HF),
atrial
fibrillation
(AF),
arteriopathy,
chronic
obstructive
pulmonary
disease
(COPD),
kidney
(KF),
which,
found
be
associated
endpoint
0.05),
lost
significance
analysis.
Therapy
aldosterone
antagonists
also
appeared
2.49,
1.52–4.08,
0.001);
whereas,
D
supplementation
beneficial.
Although
not
conclusive,
search
into
Eudravigilance
database,
combined
consulting
digital
predictive
platform
(PLATO,
polypharmacology
prediction),
potential
off-target
activities,
might
contribute
increasing
severity
infection.
Conclusions:
retrospective
clinical
furnished
evidences
other
pharmacological
treatments
course.
Frontiers in Microbiology,
Journal Year:
2022,
Volume and Issue:
13
Published: Oct. 6, 2022
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
that
causes
disease
19
(COVID-19)
has
numerous
risk
factors
leading
to
severe
with
high
mortality
rate.
Oxidative
stress
excessive
production
of
reactive
oxygen
species
(ROS)
lower
glutathione
(GSH)
levels
seems
be
a
common
pathway
associated
the
COVID-19
mortality.
GSH
is
unique
small
but
powerful
molecule
paramount
for
life.
It
sustains
adequate
redox
cell
signaling
since
physiologic
level
oxidative
fundamental
controlling
life
processes
via
signaling,
oxidation
and
tissue
damage.
The
water-soluble
tripeptide
(γ-L-glutamyl-L-cysteinyl-glycine)
present
in
cytoplasm
all
cells.
at
1–10
mM
concentrations
mammalian
tissues
(highest
concentration
liver)
as
most
abundant
non-protein
thiol
protects
against
stress.
also
activates
Kelch-like
ECH-associated
protein
1
(Keap1)-Nuclear
factor
erythroid
2-related
(Nrf2)-antioxidant
response
element
(ARE)
regulator
pathway,
releasing
Nrf2
regulate
expression
genes
control
antioxidant,
inflammatory
immune
system
responses,
facilitating
activity.
exists
thiol-reduced
disulfide-oxidized
(GSSG)
forms.
Reduced
prevailing
form
accounting
>98%
total
GSH.
GSSG
their
molar
ratio
are
indicators
functionality
its
alteration
related
various
human
pathological
including
COVID-19.
plays
prominent
role
SARS-CoV-2
infection
following
recognition
viral
S-protein
by
angiotensin
converting
enzyme-2
receptor
pattern
receptors
like
toll-like
4,
activation
transcription
nuclear
kappa
B,
subsequently
activate
nicotinamide
adenine
dinucleotide
phosphate
(NADPH)
oxidase
(NOX)
succeeded
ROS
production.
depletion
may
have
pathophysiology,
host
severity
Therapies
enhancing
could
become
cornerstone
reduce
fatal
outcomes
increasing
prevent
subdue
disease.
value
makes
research
field
biology
medicine
key
Microbiology Spectrum,
Journal Year:
2023,
Volume and Issue:
11(2)
Published: Feb. 28, 2023
COVID-19
is
characterized
by
diverse
clinical
outcomes
that
include
asymptomatic
to
mild
manifestations
or
severe
disease
and
death.
Infection
SARS-CoV-2
activates
inflammatory
metabolic
responses
drive
protection
pathology.